(1) |
The Form 10-K for the year ended December 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2) |
The information contained in the Form 10-K for the year ended December 31, 2020 fairly presents, in all material respects, the financial condition and results of
operations of Chembio Diagnostics, Inc. for the periods presented therein.
|
Dated: March 11, 2021
|
/s/ Richard L. Eberly
|
|
|
Richard L. Eberly
|
|
|
Chief Executive Officer and President
|
|
Dated: March 11, 2021
|
/s/ Neil A. Goldman
|
|
|
Neil A. Goldman
|
|
|
Executive Vice President and Chief Financial Officer
|
|